Informationen:
Fehler:
ID
21870
Beschreibung
Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00411528
Link
https://clinicaltrials.gov/show/NCT00411528
Stichworte
Versionen (1)
- 05.05.17 05.05.17 -
Hochgeladen am
5. Mai 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Metastatic Hormone Refractory Prostate Cancer DRKS00007583 NCT00411528
Eligibility Metastatic Hormone Refractory Prostate Cancer NCT00411528
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Metastatic Hormone Refractory Prostate Cancer NCT00411528
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
must be ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Prostate carcinoma
Item
confirmed and documented diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
Disease Progression Evidence of | Hormone refractory prostate cancer
Item
confirmed and documented evidence of progression of disease (hormone refractory)
boolean
C0242656 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C1328504 (UMLS CUI [2])
C0332120 (UMLS CUI [1,2])
C1328504 (UMLS CUI [2])
Low testosterone levels
Item
low testosterone levels
boolean
C4011625 (UMLS CUI [1])
Chemotherapy naive
Item
chemotherapy-naïve
boolean
C0392920 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0919936 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
recent radiation therapy (within 4 weeks)
boolean
C1522449 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
known brain metastasis
boolean
C0220650 (UMLS CUI [1])
Peripheral Neuropathy
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
Diarrhea
Item
active diarrhea
boolean
C0011991 (UMLS CUI [1])
Illness | Heart Disease | Diabetes Mellitus | Communicable Diseases chronic | Communicable Diseases Uncontrolled
Item
significant illnesses such as heart disease, diabetes, or chronic or uncontrolled infections
boolean
C0221423 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0018799 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Allergic Reaction epothilone B | Allergic Reaction docetaxel | Prednisone allergy | Allergic Reaction Compound Similar
Item
allergic reactions to patupilone or docetaxel or prednisone or similar compounds
boolean
C1527304 (UMLS CUI [1,1])
C0297960 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C0571591 (UMLS CUI [3])
C1527304 (UMLS CUI [4,1])
C1706082 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
C0297960 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C0571591 (UMLS CUI [3])
C1527304 (UMLS CUI [4,1])
C1706082 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])